Track NKTR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
NKTR - Nektar Therapeutics (NKTR) has a earnings per share of -$1.78, up 50.7% over the past year.
Latest EPS (Actual)
-$1.78
Beat Rate
62.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$1.48 | -$1.78 | Miss | -20.27% |
| Mar 2026 | -$3.50 | -$1.29 | Beat | +63.10% |
| Nov 2025 | -$2.79 | -$1.87 | Beat | +32.97% |
| Aug 2025 | -$3.13 | -$2.95 | Beat | +5.75% |
| May 2025 | -$2.82 | -$3.61 | Miss | -28.01% |
| Mar 2025 | -$0.13 | -$0.15 | Miss | -15.38% |
| Nov 2024 | -$3.09 | -$2.65 | Beat | +14.24% |
| Aug 2024 | -$3.01 | -$2.81 | Beat | +6.64% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.